This is a pilot study to determine if proton radiation therapy can provide effective and safe treatment for subfoveal neovascularization membrane (SNVM). The study will include adult patients over the age of 50 with macular degeneration, who have subfoveal neovascularization membrane (SNVM) and have had prior treatment with Avastin or Lucentis. Additional purposes of this study are to see if the growth of neovascular membranes can be stopped and overall vision improved with the use of protons and assess the side effects associated with this treatment.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of participants with acute and late morbidity of the eye as a measure of safety
Timeframe: 1 year after completion of radiation treatment
Number of participants with cessation of growth of neovascular membranes.
Timeframe: 1 year after completion of radiation treatment
Visual acuity per comprehensive eye exam
Timeframe: 1 year after completion of radiation treatment
Frequency of intravitreal injections following radiation treatment
Timeframe: 1 year after completion of radiation treatment